InvestorsHub Logo
Followers 85
Posts 5198
Boards Moderated 1
Alias Born 01/23/2010

Re: None

Saturday, 07/22/2017 3:13:44 PM

Saturday, July 22, 2017 3:13:44 PM

Post# of 130743
EPGL's David Markus. Progress continues. EPGL leading the way with all things AR.
Dr. David T. Markus, Ph.D. serves as a Vice President of BioMems Development at EP Global Communications, Inc. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He served as a Principal Investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macro electronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery. Dr. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.